Medical aid coverage of medical cannabis in SA — what schemes do and do not cover

Section 21 medicines, by definition, are not registered for general sale in South Africa. Medical schemes set their formularies based on registered medicines with established cost-effectiveness data. Section 21 cannabinoid products have neither — each is patient-and-product-specific, dose-titrated individually, and accessed under temporary regulatory authorisation rather than long-term registration.

Schemes also point to the unpredictable cost variance between products and the lack of head-to-head comparisons against conventional alternatives. Without that data, scheme actuaries cannot price-in coverage risk. The result is that even prescription benefits funds (PMBs) typically exclude Section 21 cannabinoid medication.

**Doctor consultation** — under code 0130 (telemedicine consultation), some schemes will reimburse part or all of the R500 consultation fee. Coverage varies dramatically scheme-to-scheme, plan-tier-to-tier, and whether your overall consultation benefit is exhausted. Always confirm directly with your scheme before booking.

**Diagnostic workup** — if your underlying condition (chronic pain workup, MRI for MS, EEG for epilepsy) requires investigations, those are typically scheme-covered like any other clinical investigation, separately from the cannabinoid prescription.

**Specialist referrals** — if your case requires specialist input (neurology, pain medicine, oncology) before the cannabinoid application, the specialist consultation is scheme-covered like any other referral.

**SAHPRA Section 21 application fee** — R400 per product, statutory, paid to SAHPRA. No medical scheme covers regulatory application fees as a class, and Section 21 fees are no exception.

**Section 21 cannabinoid medication** — the dispensed product itself, regardless of which pharmacy fills it. This is consistent across SA medical schemes as of 2026.

Three steps to clarify before booking:

First, **call your scheme** and ask specifically about consultation code 0130 reimbursement on your specific plan tier. Get the answer in writing if possible.

Second, **clarify whether out-of-network telemedicine consultations are reimbursed** — some plans cover only network practitioners, and Docto24 may or may not be in your scheme's network depending on the provider.

Third, **do not rely on what the scheme broker said two years ago** — scheme rules around telemedicine and around Section 21 specifically have shifted multiple times in recent years and continue to evolve.